Barinthus Biotherapeutics Plc
Barinthus Biotherapeutics Plc is an active company incorporated on 22 March 2021 with the registered office located in Altrincham, Greater Manchester. Barinthus Biotherapeutics Plc was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13282620
Public limited company
Age
4 years
Incorporated 22 March 2021
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 21 March 2025 (7 months ago)
Next confirmation dated 21 March 2026
Due by 4 April 2026 (5 months remaining)
Last change occurred 6 months ago
Accounts
Submitted
For period 1 Jan ⟶ 31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 June 2026 (8 months remaining)
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Mr Alexander Eric Hammacher and Alex Eric Hammacher are mutual people.
Active
Mr Alexander Eric Hammacher and Alex Eric Hammacher are mutual people.
Active
Mr Alexander Eric Hammacher and Alex Eric Hammacher are mutual people.
Active
Alex Eric Hammacher is a mutual person.
Active
Brands
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies that guide T cells to address chronic infectious diseases and autoimmunity.
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Dec 2024
For period 31 Dec ⟶ 31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£89.58M
Decreased by £186.86M (-68%)
Total Liabilities
-£2.11M
Increased by £680K (+47%)
Net Assets
£87.47M
Decreased by £187.54M (-68%)
Debt Ratio (%)
2%
Increased by 1.84% (+355%)
Get Credit Report
Discover Barinthus Biotherapeutics Plc's Credit Score, how much credit you can offer them, and how likely they are to repay you
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
